Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Medrxiv : the Preprint Server for Health Sciences|July 25, 2025
Spinal Cord Versus Brain Imaging Biomarkers of Multiple Sclerosis Trajectory Combining 7T and 3T MRIAlessandro Miscioscia, Constantina A Treaba, Elena Barbuti, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 29, 2025
Comparative effectiveness, safety and persistence of ocrelizumab versus natalizumab in multiple sclerosis: A real-world, multi-center, propensity score-matched studyElena Barbuti, Alessia Castiello, Valeria Pozzilli, et al.
Brain Communications|April 2, 2026
Spinal cord versus brain imaging biomarkers of multiple sclerosis trajectory combining 7T and 3T MRIAlessandro Miscioscia, Constantina A Treaba, Elena Barbuti, et al.
Journal of the Neurological Sciences|March 4, 2026
Predictors of short-term, relapse-independent progression in multiple sclerosis: A machine learning approach based on clinical data and conventional MRI-derived featuresAntonio Ianniello, Elena Barbuti, Maria Francesca Capobianco, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 23, 2026
Clinical, structural, and functional MRI features predicting PIRMA at 5-year follow-up in multiple sclerosisElena Barbuti, Claudia Piervincenzi, Viola Baione, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 23, 2026
Neurofilament light chain as a surrogate candidate for disease activity in multiple sclerosis (LUMINOUS)-A meta-regression of randomized controlled trialsRoxanne Pretzsch, Sahla El Mahdaoui, Poljanka Johnson, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 5, 2025
The Italian Multiple Sclerosis Register Experience With Cladribine: Impact on Relapses, PIRA, and Treatment Sequencing Strategies EvaluationTommaso Guerra, Massimiliano Copetti, Chiara Zanetta, et al.
Neurology and Therapy|June 2, 2022
Predictors of Cladribine Effectiveness and Safety in Multiple Sclerosis: A Real-World, Multicenter, 2-Year Follow-Up StudyMaria Petracca, Serena Ruggieri, Elena Barbuti, et al.
Therapeutic Advances in Neurological Disorders|December 31, 2025
Real-world experience with cladribine tablets in people with multiple sclerosis: effectiveness data from a multicenter Italian studyMatteo Lucchini, Giovanna Borriello, Shalom Haggiag, et al.
Neurology and Therapy|September 19, 2025
Real-World 24-Month Outcomes of Ofatumumab in Relapsing Multiple Sclerosis: Efficacy, Safety, and the Impact of FrailtyGina Ferrazzano, Roberta Fantozzi, Shalom Haggiag, et al.
Pageof 2